BBOT · Forms 3, 4, 5
Insider trades at BridgeBio Oncology Therapeutics, Inc.
No open-market insider buys or sells at BridgeBio Oncology Therapeutics, Inc. in the last 90 days; 5 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for BridgeBio Oncology Therapeutics, Inc. (BBOT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Marc Cobo | Principal Accounting Officer | Tax withholding | 126 | $3.94 | $496 | Form 4 | |
| Idan Elmelech | COO & Principal Financial Ofcr | Tax withholding | 343 | $3.94 | $1K | Form 4 | |
| Pedro Beltran | President and CEO | Tax withholding | 1,047 | $3.94 | $4K | Form 4 | |
| Yong Ben | Chief Med & Dev Officer | Tax withholding | 1,047 | $3.94 | $4K | Form 4 | |
| Marc Cobo | Principal Accounting Officer | Award | 9,038 | Form 4 | |||
| Marc Cobo | Principal Accounting Officer | Tax withholding | 203 | $5.52 | $1K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.